Thalys Medical Technology Group Corporation (SHA:603716)
China
· Delayed Price · Currency is CNY 13.14
+0.38 (2.98%)
May 30, 2025, 11:29 AM CST
SHA:603716 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -226.72 | -209.24 | -158.57 | -153.73 | -49.51 | 57.56 | Upgrade
|
| Depreciation & Amortization | 50.99 | 50.99 | 74.71 | 84.35 | 96.28 | 76.59 | Upgrade
|
| Other Amortization | 11.59 | 11.59 | 9.7 | 23.22 | 19.58 | 21.39 | Upgrade
|
| Loss (Gain) From Sale of Assets | -7.62 | -7.62 | 2.54 | 0.02 | -0.4 | 0.16 | Upgrade
|
| Asset Writedown & Restructuring Costs | 24.18 | 24.18 | 35.91 | 19.18 | 0.72 | 0.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | 68.01 | 68.01 | 11.3 | 31.8 | 25.66 | -0.75 | Upgrade
|
| Provision & Write-off of Bad Debts | -38.53 | -38.53 | 28.17 | 91.54 | 62.11 | 21.46 | Upgrade
|
| Other Operating Activities | 71.83 | 77.83 | 129.87 | 64.36 | 110.78 | 100.25 | Upgrade
|
| Change in Accounts Receivable | 65.62 | 65.62 | 5.19 | -171.05 | -457.83 | -445.06 | Upgrade
|
| Change in Inventory | 15.44 | 15.44 | 79.15 | 42.89 | -61.16 | -53.14 | Upgrade
|
| Change in Accounts Payable | 11.43 | 11.43 | -16.88 | 39.91 | 151.89 | 237.63 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | -4.58 | -2.64 | 10.21 | Upgrade
|
| Operating Cash Flow | 76.12 | 99.6 | 125.89 | 28.12 | -133.52 | 9.94 | Upgrade
|
| Operating Cash Flow Growth | 26.66% | -20.89% | 347.65% | - | - | -89.41% | Upgrade
|
| Capital Expenditures | -20.66 | -23.21 | -40.83 | -54.64 | -60.19 | -127.7 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.46 | 0.54 | 0.31 | 0.24 | 14.44 | 0.17 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 0.25 | Upgrade
|
| Divestitures | 62.72 | 27.49 | -4.94 | -16.73 | 2.65 | 3.19 | Upgrade
|
| Investment in Securities | -12.49 | -12.49 | 49.12 | 121.62 | -77.63 | -164.98 | Upgrade
|
| Other Investing Activities | 10.24 | 0 | 11.52 | 109.22 | 6 | 0.1 | Upgrade
|
| Investing Cash Flow | 40.27 | -7.67 | 15.19 | 159.71 | -114.72 | -288.98 | Upgrade
|
| Long-Term Debt Issued | - | 443.05 | 892.36 | 1,235 | 1,112 | 1,994 | Upgrade
|
| Long-Term Debt Repaid | - | -516.38 | -1,075 | -1,494 | -962.8 | -1,516 | Upgrade
|
| Net Debt Issued (Repaid) | -48.13 | -73.33 | -182.17 | -259.4 | 149.39 | 478.43 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1.59 | - | - | Upgrade
|
| Repurchase of Common Stock | -29.99 | -29.72 | - | - | -50.27 | - | Upgrade
|
| Common Dividends Paid | -58.45 | -59.88 | -38.8 | -52.25 | -49.52 | -59.31 | Upgrade
|
| Other Financing Activities | 16.27 | 14.66 | 6.66 | -6.58 | 11.78 | 21.83 | Upgrade
|
| Financing Cash Flow | -120.3 | -148.27 | -214.31 | -316.64 | 61.39 | 440.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | 0 | -0.04 | 0.03 | -0.03 | - | Upgrade
|
| Net Cash Flow | -3.93 | -56.35 | -73.26 | -128.78 | -186.88 | 161.92 | Upgrade
|
| Free Cash Flow | 55.46 | 76.39 | 85.06 | -26.52 | -193.71 | -117.76 | Upgrade
|
| Free Cash Flow Growth | 181.13% | -10.20% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 3.44% | 4.22% | 4.24% | -1.15% | -7.45% | -5.54% | Upgrade
|
| Free Cash Flow Per Share | 0.27 | 0.40 | 0.44 | -0.14 | -0.98 | -0.59 | Upgrade
|
| Cash Income Tax Paid | 87.3 | 96.78 | 110.37 | 150.82 | 139.56 | 128.93 | Upgrade
|
| Levered Free Cash Flow | 388.71 | 231.71 | 375.96 | 236.34 | -184.22 | -321.74 | Upgrade
|
| Unlevered Free Cash Flow | 423.4 | 267.76 | 423.58 | 298.07 | -132.49 | -285.66 | Upgrade
|
| Change in Net Working Capital | -401.74 | -220.35 | -391.82 | -254.83 | 247.42 | 364.89 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.